Trexquant Investment’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,968
| Closed | -$653K | – | 1562 |
|
|
2022
Q3 | $653K | Buy |
7,968
+1,559
| +24% | +$128K | 0.02% | 698 |
|
|
2022
Q2 | $434K | Buy |
6,409
+4,468
| +230% | +$303K | 0.02% | 910 |
|
|
2022
Q1 | $215K | Sell |
1,941
-12,784
| -87% | -$1.42M | 0.01% | 1170 |
|
|
2021
Q4 | $1.42M | Buy |
14,725
+12,312
| +510% | +$1.19M | 0.09% | 291 |
|
|
2021
Q3 | $211K | Buy |
2,413
+777
| +47% | +$67.9K | 0.02% | 934 |
|
|
2021
Q2 | $253K | Sell |
1,636
-641
| -28% | -$99.1K | 0.02% | 796 |
|
|
2021
Q1 | $359K | Sell |
2,277
-150
| -6% | -$23.7K | 0.03% | 667 |
|
|
2020
Q4 | $563K | Buy |
+2,427
| New | +$563K | 0.06% | 401 |
|
|
2020
Q3 | – | Sell |
-2,843
| Closed | -$808K | – | 1383 |
|
|
2020
Q2 | $808K | Buy |
+2,843
| New | +$808K | 0.06% | 480 |
|
|
2019
Q3 | – | Sell |
-1,127
| Closed | -$101K | – | 989 |
|
|
2019
Q2 | $101K | Sell |
1,127
-539
| -32% | -$48.3K | 0.01% | 745 |
|
|
2019
Q1 | $146K | Buy |
+1,666
| New | +$146K | 0.01% | 906 |
|
|
2018
Q3 | – | Sell |
-783
| Closed | -$200K | – | 1074 |
|
|
2018
Q2 | $200K | Sell |
783
-1,285
| -62% | -$328K | 0.01% | 791 |
|
|
2018
Q1 | $416K | Buy |
+2,068
| New | +$416K | 0.03% | 696 |
|
|
2017
Q3 | – | Sell |
-1,490
| Closed | -$202K | – | 911 |
|
|
2017
Q2 | $202K | Buy |
+1,490
| New | +$202K | 0.06% | 668 |
|
|
2017
Q1 | – | Sell |
-1,934
| Closed | -$273K | – | 1202 |
|
|
2016
Q4 | $273K | Buy |
+1,934
| New | +$273K | 0.04% | 687 |
|
|
2016
Q1 | – | Sell |
-2,660
| Closed | -$529K | – | 1050 |
|
|
2015
Q4 | $529K | Buy |
+2,660
| New | +$529K | 0.05% | 660 |
|